Nasdaq Rphm News Today

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Free Report)’s stock price traded up 0.6% on Tuesday . The company traded as high as $1.71 and last traded at $1.71. 86,279 shares were traded during trading, a decline of 73% from the average session volume of 318,690 shares. The stock had previously closed at $1.70. Analyst Upgrades […]

Pale Fire Capital SE purchased a new stake in shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 14,851 shares of the company’s stock, valued at approximately $113,000. A number of other institutional investors have also […]

Pale Fire Capital SE purchased a new stake in Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Free Report) during the third quarter, HoldingsChannel.com reports. The firm purchased 14,851 shares of the company’s stock, valued at approximately $113,000. A number of other institutional investors have also recently modified their holdings of RPHM. Northern Trust Corp boosted its stake […]

SVB Leerink reaffirmed their market perform rating on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a research report report published on Friday, MarketBeat Ratings reports. Several other equities research analysts also recently commented on the company. Bank of America downgraded Reneo Pharmaceuticals from a buy rating to an underperform rating in a report […]

HC Wainwright downgraded shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) from a buy rating to a neutral rating in a research report report published on Friday morning, Marketbeat Ratings reports. Several other research firms also recently commented on RPHM. LADENBURG THALM/SH SH downgraded shares of Reneo Pharmaceuticals from a buy rating to a neutral […]

Reneo Pharmaceuticals (NASDAQ:RPHM – Get Free Report)‘s stock had its “hold” rating reissued by Jefferies Financial Group in a research report issued on Friday, Marketbeat Ratings reports. Other equities analysts have also issued research reports about the stock. LADENBURG THALM/SH SH lowered shares of Reneo Pharmaceuticals from a “buy” rating to a “neutral” rating in […]

IRVINE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the...

HC Wainwright reaffirmed their buy rating on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $30.00 price objective on the stock. Separately, Bank of America assumed coverage on shares of Reneo Pharmaceuticals in a research note on Monday, July 3rd. They issued […]

Reneo Pharmaceuticals (NASDAQ:RPHM – Get Free Report) and PDS Biotechnology (NASDAQ:PDSB – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk. Analyst Recommendations This is a breakdown of […]

HC Wainwright assumed coverage on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a research report report published on Monday morning, MarketBeat reports. The brokerage issued a buy rating and a $30.00 price objective on the stock. HC Wainwright also issued estimates for Reneo Pharmaceuticals’ Q3 2023 earnings at ($0.60) EPS, Q4 2023 earnings […]